Professor Paul Seabright (Toulouse School of Economics and CEPR)

 

Professor Patrick Legros (ECARES, ULB and CEPR)

 

Registration and buffet lunch 12:15. 

Presentation and Discussion 13:00-14:00 .

 

An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy. In this presentation, based on a policy paper co-authored by Pierre Dubois, Wing Man Wynne Lam, Olivier de Mouzon and Fiona Scott-Morton, Paul Seabright will explore the elasticity of innovation and its implications and relevance to policy discussion.

 

Should you require further assistance, please contact Nadine Clarke, nclarke@cepr.org or +44 20 7183 8808